Since Lancaster et al.(2013)first described the formation of self-organizing cerebral organoids for modeling neurodevelopmental disorders,it became evident that
Oral 4-aminopyridine(4-AP)is clinically used for symptomatic relief in multiple sclerosis and we recently demonstrated that systemic 4-AP had previously unknown
Mucin-like glycoproteins have established roles in epithelial boundary protection and lubricative roles in some tissues.This mini-review illustrates alternative